ECL
Ecolab Inc.Price & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted operating income margin non-GAAP | 16.7% | First Quarter Ended March 31 | — |
| Ecolab Digital sales | $99M | First Quarter Ended March 31 | — |
| adjusted diluted EPS growth non-GAAP | 13% | Q1 2026 call | — |
| Food & Beverage growth | 5% | Q1 2026 call | — |
| Life Sciences growth | 11% | Q1 2026 call | — |
| organic operating income margin | 16.8% | Q1 2026 call | — |
| organic operating income margin expansion | 70 | Q1 2026 call | — |
| organic sales growth | 4% | Q1 2026 call | — |
| Pest Elimination growth | 7% | Q1 2026 call | — |
| Specialty growth | 9% | Q1 2026 call | — |
| value pricing | 3% | Q1 2026 call | — |
| volume growth | 1% | Q1 2026 call | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ECL
this stock
Ecolab Inc.
|
$75.92B | +3.0% | +2.2% | 36.5 | 1.3% |
|
LIN
Linde PLC
|
$241.73B | +23.0% | +3.0% | 34.7 | 1.4% |
|
AIQUF
L Air Liquide SA /Fi
|
$127.67B | +8.7% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$81.02B | +1.9% | +26.4% | 31.6 | 3.2% |
|
APD
Air Products & Chemicals, Inc.
|
$66.67B | +22.9% | -0.5% | 31.7 | 1.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ECL | -4.7% | +1.6% | -0.9% | -3.2% | +3.0% |
| SPY | +0.6% | +1.4% | +11.0% | +0.7% | +10.3% |
| vs SPY | -5.3% | +0.3% | -11.9% | -3.9% | -7.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.